The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools, for the provision of NanoString GeoMX Digital Spatial Profiling and nCounter MAX System equipment and services to support the Laboratory of Pathology's Single-Cell RNA Facility. The $496,250 contract has a completion date of September 3, 2020 and does not utilize a...
This is a firm-fixed-price contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science research tools. The contract, valued at $8,832.00, was awarded by the National Cancer Institute, a component of the National Institutes of Health, and does not have a set-aside designation. Nanostring will provide the agency with its proprietary nCounter and GeoMx analysis systems, as well as associated reagents, assays, and testing...
This is a $24,999 firm fixed price contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Nanostring Technologies, Inc., a publicly traded provider of specialized genomic analysis equipment and services. The contract is a BPA call, indicating it was issued under a larger Blanket Purchase Agreement. Nanostring will provide the agency with its proprietary nCounter Analysis Systems, GeoMx Digital Spatial Profilers, custom gene expression panels, and related...
This is a Firm Fixed Price BPA Call contract awarded to Nanostring Technologies, Inc. by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract has a ceiling value of $6,126.00 and an ultimate completion date of October 8, 2017. Nanostring Technologies is a publicly traded manufacturer of life science tools for translational research and molecular diagnostics. Under this award, Nanostring is providing specialized laboratory equipment,...
This is a firm fixed price contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded life sciences company that specializes in advanced genomic analysis platforms. The contract is a blanket purchase agreement valued at $4,226.00 with a period of performance through August 31, 2017. Nanostring will provide the National Cancer Institute with its proprietary nCounter Analysis...
This is a $10,892 firm fixed-price contract awarded by the National Cancer Institute (NCI) to Nanostring Technologies, Inc. for the delivery of specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs. The contract is a call order under a larger $596,881.45 indefinite delivery/indefinite quantity (IDIQ) contract with the USDA Agricultural Research Service, as well as a $2.8...
This is a $9,900 firm fixed price BPA call awarded by the National Cancer Institute (NCI) to Nanostring Technologies, Inc. The contract is for the provision of Nanostring's proprietary NanoString nCounter Analysis Systems and GeoMx Digital Spatial Profilers, along with associated reagents and consumables, to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs across various government agencies. Nanostring Technologies is a publicly held provider of...
This firm fixed-price purchase order for $16,770.50 was awarded to Nanostring Technologies, Inc. by the National Institute of Child Health and Human Development, a civilian federal agency, for the delivery of GeoMx Collection Plates, Profiling Kits, Slides, and related products. The award has an ultimate completion date of December 30, 2024 and was not set aside for any specific business type. Nanostring Technologies is a publicly-held provider of advanced genomic analysis platforms, including...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a publicly held provider of life science tools, for HU V3 MIRNA REAGENTS. The contract has a potential value of $24,339.90 and a completion date of September 5, 2023. Nanostring Technologies has an extensive history of providing specialized laboratory equipment, consumables, and testing services to support genomic,...
This is a $127,500 firm fixed-price Purchase Order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Nanostring Technologies, Inc. for the NanoString nCounter Analysis System. The contract does not have a set-aside designation. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools. Through this contract, they are supplying specialized laboratory equipment, reagents, assays,...